Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
28.00
+0.10 (0.36%)
Aug 12, 2026, 4:00 PM EDT - Market closed

KMTS Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, KMTS stock has a consensus rating of "Buy" and an average price target of $30. The average 1-year stock price forecast is 7.14% higher than the current stock price, while the lowest is $28 (0.00%) and the highest is $32 (+14.29%).

Price Target: $30 (+7.14%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$28$30$30$32
Change0.00%+7.14%+7.14%+14.29%

Analyst Ratings

The average analyst rating for KMTS stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJan '26Mar '26Apr '26May '26Jul '26Aug '26
Strong Buy555555
Buy111112
Hold111111
Sell000000
Strong Sell000000
Total777778

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Buy
Initiates
$30
BuyInitiates$30+7.14%Aug 10, 2026
Oppenheimer
Oppenheimer
Hold
Initiates
n/a
HoldInitiatesn/an/aJul 21, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$30
BuyMaintains$30+7.14%Jul 15, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$30
BuyMaintains$30+7.14%Jul 15, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$30
BuyReiterates$30+7.14%Jul 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
137.06M
from 95.13M
Increased by 44.09%
Revenue Next Year
193.81M
from 137.06M
Increased by 41.40%
EPS This Year
-2.31
from -1.71
EPS Next Year
-2.02
from -2.31
Fiscal YearFY 2021FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingApr 30, 2021Apr 30, 2023Apr 30, 2024Apr 30, 2025Apr 30, 2026Apr 30, 2027
Revenue
-7.63M27.81M59.82M95.13M137.06M
Revenue Growth
--264.54%115.05%59.03%44.09%
Gross Profit
--10.65M362.00K24.21M48.86M80.14M
Gross Margin
--139.59%1.30%40.47%51.37%58.47%
Operating Income
-32.71M-80.42M-85.06M-106.38M-134.74M-135.12M
Net Income
-34.10M-84.24M-94.12M-113.81M-131.61M-135.84M
EPS
-----1.71-2.31
Free Cash Flow
-18.53M--40.92M-67.53M-75.76M-114.63M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202720282029
High137.3M
Avg137.1M
Low136.9M

Revenue Growth

Revenue Growth202720282029
High
44.3%
Avg
44.1%
Low
43.9%

EPS Forecast

EPS202720282029
High-2.28
Avg-2.31
Low-2.33

EPS Growth

EPS Growth202720282029
High-
Avg-
Low-